ORLANDO, Fla. — Another high-blood pressure medicine has been recalled because the drug has more than acceptable trace amounts of a carcinogen.
- Several lots of irbesartan tablets recalled by Solco Healthcare
- Full list of recalled irbesartan tablets
- PREVIOUS STORY: Company Expands Recall of Popular Blood-Pressure Drug Losartan
Solco Healthcare LLC recalled one lot of irbesartan 150 mg and 300 mg tablets, and seven lots of irbesartan and hydrochlorothiazide-combination 150 mg and 300 mg tablets.
The FDA has already announced several recalls for irbesartan in the past few months. They've also issued recalls for a number of other blood pressure medications, including losartan and valsartan.
All of the drugs have unacceptable levels Nitrosodiethylamine, or NDEA, in the drugs' active ingredient.
To see a full list of drugs under recall, head to the FDA website.